Syros Pharmaceuticals (SYRS) Insider Trading & Ownership $0.02 +0.02 (+1,143.75%) As of 03:18 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Syros Pharmaceuticals (NASDAQ:SYRS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage12.26%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$206.49KNumber OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$46.38K Get SYRS Insider Trade Alerts Want to know when executives and insiders are buying or selling Syros Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SYRS Insider Buying and Selling by Quarter Syros Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/2/2024Nancy A SimonianDirectorSell37,070$0.27$10,008.90 11/25/2024Nancy A SimonianDirectorSell134,713$0.27$36,372.51 9/12/2024Jason HaasCFOBuy45,344$1.68$76,177.92 9/10/2024Conley CheeCEOBuy50,000$1.51$75,500.00 9/10/2024Jason HaasCFOBuy35,363$1.55$54,812.65 (Data available from 1/1/2013 forward) SYRS Insider Trading Activity - Frequently Asked Questions Who is on Syros Pharmaceuticals' Insider Roster? The list of insiders at Syros Pharmaceuticals includes Conley Chee, David Roth, Eric R Olson, Jason Haas, Nancy A Simonian, Richard A Young, Srinivas Akkaraju, and Timothy Tyson. Learn more on insiders at SYRS. What percentage of Syros Pharmaceuticals stock is owned by insiders? 12.26% of Syros Pharmaceuticals stock is owned by insiders. Learn more on SYRS's insider holdings. Which Syros Pharmaceuticals insiders have been buying company stock? The following insiders have purchased SYRS shares in the last 24 months: Conley Chee ($75,500.00), Jason Haas ($130,990.57), and Srinivas Akkaraju ($3,999,998.34). How much insider buying is happening at Syros Pharmaceuticals? Insiders have purchased a total of 1,035,684 SYRS shares in the last 24 months for a total of $4,206,488.91 bought. Which Syros Pharmaceuticals insiders have been selling company stock? The following insiders have sold SYRS shares in the last 24 months: David Roth ($25,580.65), Nancy A Simonian ($46,381.41), and Richard A Young ($178,365.44). How much insider selling is happening at Syros Pharmaceuticals? Insiders have sold a total of 213,057 Syros Pharmaceuticals shares in the last 24 months for a total of $250,327.50 sold. Syros Pharmaceuticals Key ExecutivesMr. Conley Chee (Age 54)CEO, President & Director Compensation: $672.24kDr. Richard A. Young Ph.D. (Age 70)Scientific Founder, Member of Scientific Advisory Board & Director Compensation: $51.75kMr. Jason Haas (Age 56)Chief Financial Officer Compensation: $672.22kDr. David A. Roth M.D. (Age 61)Chief Medical Officer Compensation: $715.73kDr. James E. Bradner M.D. (Age 52)Founder Dr. Nathanael S. Gray Ph.D.Scientific Founder & Member of Scientific Advisory BoardMs. Karen Hunady M.S.Director of Corporate Communications & Investor RelationsMr. Gerald E. Quirk Esq. (Age 56)J.D., Chief Legal Officer & Head of Business Development Compensation: $127.07kMs. Lisa RobertsVice President of Human ResourcesMs. Kristin Stephens (Age 51)Chief Development Officer More Insider Trading Tools from MarketBeat Related Companies Smart for Life Insider Transactions Vaxxinity Insider Transactions Evelo Biosciences Insider Transactions Comera Life Sciences Insider Transactions Calithera Biosciences Insider Transactions Ampio Pharmaceuticals Insider Transactions PaxMedica Insider Transactions Clever Leaves Insider Transactions eFFECTOR Therapeutics Insider Transactions biote Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Buy, Sell, or Hold? Insiders Pile Into These 3 Healthcare StocksInsiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift45 Stocks Insiders Are Selling That Analysts Say BuyStrategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying This page (NASDAQ:SYRS) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Syros Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Syros Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access